Activities

Viral infectious diseases represent a worldwide threat to public health and economy.

Activities of the group include surveillance, diagnosis, outbreak investigations, molecular epidemiology and immunity against various viral diseases. Information on virus prevalence, variability and pathogenicity is important to public health decision makers to control and manage infectious diseases.

As WHO Collaborating Centre for Measles and European Regional Reference Laboratory for Measles and Rubella, the interdisciplinary team has initiated research, capacity building and quality assurance projects in numerous countries.

Besides the worldwide WHO laboratory network, major collaborators include the Ministries of Health and Foreign Affairs in Luxembourg as well as the Avian Influenza and Newcastle disease network and the Institut Pasteur du Laos.

Research projects

  • WHO National Reference Laboratory for Measles and Rubella, National Reference Laboratory for avian influenza and Newcastle disease : laboratory diagnosis of cases in Luxembourg, national disease surveillance
  • WHO European Regional Reference Laboratory for Measles and Rubella: case and outbreak confirmation, virus characterization and molecular epidemiology, quality assurance of laboratory testing for WHO National Reference Laboratories in 22 countries, capacity building
  • Microbiology for Development IV and Luxembourg-Laos Partnership for Research and Capacity Building in Infectious Disease Surveillance (PaReCIDS): surveillance of viral diseases of public health and economic relevance, capacity building
  • Nucleic acid signatures of elusive pathogens (NUPATH): development of the Next Generation Sequencing technology for the detection and characterization of viral and bacterial pathogens
  • Diverse funding sources supporting smaller projects or specific studies on viral infections

Featured Publications

Hepatitis B virus in Lao dentists: A cross-sectional serological study.

  • Clinical and Applied Virology
May 01, 2021
2021 May. Ann Hepatol.22:100282. Online ahead of print.
By:
  • Mangkara B
  • Xaydalasouk K
  • Chanthavilay P
  • Kounnavong S
  • Sayasone S
  • Muller CP
  • Paboriboune P
  • Black AP.

SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg.

  • Clinical and Applied Virology
  • Public Health Expertise
  • Allergy and Clinical Immunology
  • Deep Digital Phenotyping Research Unit
May 01, 2021
2021 May. Lancet Regl Health Europe.4:100056. In press.
By:
  • Wilmes P
  • Zimmer J
  • Schulz J
  • Glod F
  • Veiber L
  • Mombaerts L
  • Rodrigues B
  • Aalto A
  • Pastore J
  • Snoeck CJ
  • Ollert M
  • Fagherazzi G
  • Mossong J
  • Goncalves J
  • Skupin A
  • Nehrbass U.
See all publications

Contacts

Judith Hübschen

Ph.D.

29, rue Henri Koch
L-4354Esch-sur-Alzette
Luxembourg
Tel. : +352 26970-609

Chantal Snoeck

MS - PhD

29, rue Henri Koch
L-4354 Esch-Sur-Alzette
LUXEMBOURG
Tel. : +352 26 970 627